Connecticut Innovations has reported final investment figures from its recently completed fiscal year. Between July 1, 2019, and June 30, 2020, CI invested $43.2 million in Connecticut-based, early-stage companies via 135 individual transactions.
CI invested $25.8 million in bioscience and healthcare companies, $15.9 million in information technology companies and $1.5 million in other Connecticut-based companies. CI’s transactions leveraged an additional $436 million in outside capital.